+32.6%
CVS vs EFX
-11.5%
+44.1%
-44.0%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | EFX | Excess | Alpha |
|---|---|---|---|---|
| 1D | +1.0% | +0.4% | +0.6% | +1.0% |
| 7D | -9.5% | -5.8% | -3.7% | -9.1% |
| 30D | -12.9% | +0.9% | -13.8% | -13.1% |
| 3M | -13.1% | -7.6% | -5.4% | -12.9% |
| 6M | -12.2% | +8.2% | -20.3% | -13.2% |
| YTD | +5.0% | -17.6% | +22.6% | +6.2% |
| 1Y | +9.6% | -13.3% | +22.9% | +10.2% |
| 3Y | +32.6% | -13.3% | +45.9% | +45.4% |
| All | +32.6% | -11.5% | +44.1% | +45.4% |
Cumulative growth
Daily Returns
Daily percentage return beside EFX.
Daily Out/Under-Performance
Portfolio return minus EFX return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × EFX return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded EFX wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling